Skip to main content
Erschienen in: Pediatric Cardiology 4/2007

01.08.2007 | ORIGINAL ARTICLE

Correlation of Plasma B-Type Natriuretic Peptide with Shunt Severity in Patients with Atrial or Ventricular Septal Defect

verfasst von: H. Ozhan, S. Albayrak, H. Uzun, S. Ordu, A. Kaya, M. Yazıcı

Erschienen in: Pediatric Cardiology | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

The goal of this study was to test the utility of bedside plasma concentration of B-type natriuretic peptide (BNP) assay as a screen for large shunts in pediatric patients with atrial septal defects (ASDs) and ventricular septal defects (VSDs). Thirty-five children at a mean age of 70 ± 129 weeks with ASD or VSD were included in the study. Nine patients had VSD and 26 had ASD. Plasma BNP values were compared with the Q p/Q s ratios derived from quantitative Doppler flow measurements. Mean BNP was 29 ± 42 pg/ml, with a range between <5 pg/ml and 208 pg/ml. Sixteen patients had Q p/Q s values >1.5 and 19 had values <1.5. The difference of mean BNP in these patient groups was statistically significant (45 ± 56 vs 14 ± 17, p = 0.03). BNP was positively correlated with shunt significance. Receiver operating characteristic curve analysis revealed a sensitivity of 69% and a specificity of 79% at a plasma BNP cut-off level of ≥20 pg/ml. Bedside measurement of BNP correlates with magnitude of ASD and VSD in children. BNP can provide information for the management of children with ASD or VSD. It can be used as part of the evaluation of a child with a preliminary diagnosis of a congenital defect.
Literatur
1.
Zurück zum Zitat Choi BM, Lee KH, Eun BL, et al. (2005) Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115:255–261CrossRef Choi BM, Lee KH, Eun BL, et al. (2005) Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115:255–261CrossRef
2.
Zurück zum Zitat Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS (2005) The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 147:38–42PubMedCrossRef Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS (2005) The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 147:38–42PubMedCrossRef
3.
Zurück zum Zitat Holmstrom H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:184–191PubMedCrossRef Holmstrom H, Hall C, Thaulow E (2001) Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90:184–191PubMedCrossRef
4.
Zurück zum Zitat Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63–F72PubMed Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63–F72PubMed
5.
Zurück zum Zitat Muta H, Ishii M, Maeno Y, Akagi T, Kato H (2002) Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 91:649–652PubMedCrossRef Muta H, Ishii M, Maeno Y, Akagi T, Kato H (2002) Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 91:649–652PubMedCrossRef
6.
Zurück zum Zitat Nagaya N, Nishikimi T, Uematsu M, et al. (1998) Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 136:297–301PubMedCrossRef Nagaya N, Nishikimi T, Uematsu M, et al. (1998) Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 136:297–301PubMedCrossRef
7.
Zurück zum Zitat Ootaki Y, Yamaguchi M, Yoshimura N, et al. (2003) Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease. J Thorac Cardiovasc Surg 126:14110–1416 Ootaki Y, Yamaguchi M, Yoshimura N, et al. (2003) Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease. J Thorac Cardiovasc Surg 126:14110–1416
8.
Zurück zum Zitat Sanders SP, Yeager S, Williams RG (1983) Measurement of systemic and pulmonary blood flow and Qp/Qs ratio using Doppler and two dimensional echocardiography. Am J Cardiol 51:952–956PubMedCrossRef Sanders SP, Yeager S, Williams RG (1983) Measurement of systemic and pulmonary blood flow and Qp/Qs ratio using Doppler and two dimensional echocardiography. Am J Cardiol 51:952–956PubMedCrossRef
9.
Zurück zum Zitat Suda K, Matsumura M, Matsumoto M (2003) Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45:249–254PubMedCrossRef Suda K, Matsumura M, Matsumoto M (2003) Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45:249–254PubMedCrossRef
10.
Zurück zum Zitat Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D (2004) Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93:340–345PubMedCrossRef Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D (2004) Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93:340–345PubMedCrossRef
11.
Zurück zum Zitat Yoshimura M, Yasue H, Okumura K, et al. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87:464–469PubMed Yoshimura M, Yasue H, Okumura K, et al. (1993) Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87:464–469PubMed
Metadaten
Titel
Correlation of Plasma B-Type Natriuretic Peptide with Shunt Severity in Patients with Atrial or Ventricular Septal Defect
verfasst von
H. Ozhan
S. Albayrak
H. Uzun
S. Ordu
A. Kaya
M. Yazıcı
Publikationsdatum
01.08.2007
Erschienen in
Pediatric Cardiology / Ausgabe 4/2007
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-006-0014-3

Weitere Artikel der Ausgabe 4/2007

Pediatric Cardiology 4/2007 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.